Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Shenzhen Stock Exchange:002675.SZ
Sector
Location
Market Cap
USD 2.02 B
Share Price
USD 2.45
Avg Daily Volume
16,093,566
Change (1 day)
0.45%
Change (1 year)
49.35%
Change (YTD)
46.48%
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT Margin for the year ending December 31, 2024: 11.00%
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT Margin is 11.00% for the year ending December 31, 2024, a -5.57% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT Margin for the year ending December 31, 2023 was 11.65%, a -16.33% change year over year.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT Margin for the year ending December 31, 2022 was 13.92%, a 25.19% change year over year.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT Margin for the year ending December 31, 2021 was 11.12%, a -42.52% change year over year.
-
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EBIT Margin for the year ending December 31, 2020 was 19.35%, a 27.32% change year over year.
StockViz
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 131.46
MRK.DE
+3.21
2.50%
Lonza Group AG
USD 706.10
LONN.SW
+5.00
0.71%
WuXi AppTec Co., Ltd.
USD 13.21
2359.HK
+0.11
0.81%
Bayer AG
USD 33.48
BAYN.DE
+0.83
2.54%
DSM-Firmenich AG
USD 99.57
DSFIR.AS
+1.79
1.83%
Teva Pharmaceutical Industries Limited
USD 18.33
TEVA.TA
+0.81
4.61%
Recordati Industria Chimica e Farmaceutica S.p.A.
USD 61.48
REC.MI
+1.01
1.67%
IDEX Corporation
USD 168.56
IEX
+6.18
3.81%
Lupin Limited
USD 22.60
LUPIN.NS
+0.13
0.58%
CSPC Innovation Pharmaceutical Co., Ltd.
USD 7.10
300765.SZ
+0.12
1.72%
Avantor, Inc.
USD 13.27
AVTR
+0.71
5.65%
Krka, d. d.
USD 231.11
KRK.WA
+1.22
0.53%
SK Inc.
USD 130.32
034730.KS
+3.12
2.46%
Pharmaron Beijing Co., Ltd.
USD 2.77
3759.HK
+0.05
1.72%
Aurobindo Pharma Limited
USD 12.02
AUROPHARMA.NS
+0.10
0.86%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 131.46
MRK.DE
+3.21
2.50%
Lonza Group AG
USD 706.10
LONN.SW
+5.00
0.71%
WuXi AppTec Co., Ltd.
USD 13.21
2359.HK
+0.11
0.81%
Bayer AG
USD 33.48
BAYN.DE
+0.83
2.54%
DSM-Firmenich AG
USD 99.57
DSFIR.AS
+1.79
1.83%
Teva Pharmaceutical Industries Limited
USD 18.33
TEVA.TA
+0.81
4.61%
Recordati Industria Chimica e Farmaceutica S.p.A.
USD 61.48
REC.MI
+1.01
1.67%
IDEX Corporation
USD 168.56
IEX
+6.18
3.81%
Lupin Limited
USD 22.60
LUPIN.NS
+0.13
0.58%
CSPC Innovation Pharmaceutical Co., Ltd.
USD 7.10
300765.SZ
+0.12
1.72%
Avantor, Inc.
USD 13.27
AVTR
+0.71
5.65%
Krka, d. d.
USD 231.11
KRK.WA
+1.22
0.53%
SK Inc.
USD 130.32
034730.KS
+3.12
2.46%
Pharmaron Beijing Co., Ltd.
USD 2.77
3759.HK
+0.05
1.72%
Aurobindo Pharma Limited
USD 12.02
AUROPHARMA.NS
+0.10
0.86%